Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0VLCVX
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
LC301-1-1 (4)
|
|||||
| Synonyms |
LC301-1-1 (4)
Click to Show/Hide
|
|||||
| Organization |
Qiguang Dejian Pharmaceutical Technology Suzhou Co ltd; Genequantum Healthcare Suzhou Co Ltd
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Structure |
|
|||||
| Antibody Name |
Ab0001-LCCTL-HC
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Dxd-1
|
Payload Info | ||||
| Linker Name |
LA301-1-1 linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
LA301-1-1-Dxd-1
|
|||||